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Abstract As the understanding of interactions between
articular cartilage and subchondral bone continues to evolve,
increased attention is being directed at treatment options for
the entire osteochondral unit, rather than focusing on the
articular surface only. It is becoming apparent that without
support from an intact subchondral bed, any treatment of the
surface chondral lesion is likely to fail. This article reviews
issues affecting the entire osteochondral unit, such as sub-
chondral changes after marrow-stimulation techniques and
meniscectomy or large osteochondral defects created by
prosthetic resurfacing techniques. Also discussed are surgi-
cal techniques designed to address these issues, including the
use of osteochondral allografts, autologous bone grafting,
next generation cell-based implants, as well as strategies
after failed subchondral repair and problems specific to the
ankle joint. Lastly, since this area remains in constant evo-
lution, the requirements for prospective studies needed to
evaluate these emerging technologies will be reviewed.
Keywords Cartilage repair  Autologous chondrocyte
implantation  Microfracture  Subchondral bone
Introduction
Articular defects can be limited to the superficial layer of
cartilage or can extend deeper, also affecting the underlying
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subchondral bone. Certain defects, such as those resulting
from osteochondritis dissecans (OCD), may in fact start in
the subchondral bone, only secondarily affecting the over-
lying cartilage. Other joint pathologies involving the sub-
chondral bone include osteonecrosis and osteochondral
fractures. There has been increased awareness that the sub-
chondral bone plays an important role even in superficial
lesions limited to the articular cartilage layer, since even
focal chondral defects, if left untreated, may increase in size
over time and result in concomitant changes in the under-
lying subchondral bone plate; either overgrowth or bone loss.
Recently, there has been an increasing interest and
awareness of the importance of the subchondral bone for its
role in the pathogenic processes, as well as the necessity to
carefully consider this structure in the treatment of articular
surface damage, in the evaluation of the results over time,
and in the determination of the patients’ prognosis. In fact,
the conditions of articular cartilage and its supporting bone
are tightly coupled and should be viewed as a connected
osteochondral unit. The biomechanical alterations caused
by (osteo)-chondral defects affect the articular cartilage
surrounding and opposing the lesion, as well as the
homeostatic balance of the entire joint. As such, there is
increased likelihood for clinical progression to more
widespread joint degeneration through mechanical disrup-
tion of joint motion, loose body formation, mechanical
wear in the involved compartment, and attrition of
opposing surfaces. This progressive decline may lead to
degenerative joint disease with earlier onset of osteoar-
thritis. Therefore, the treatment goal for large chondral or
osteochondral defects should be to restore the physiologi-
cal properties of the entire osteochondral unit, aiming to
achieve a more predictable repair tissue that closely
resembles native articular surface and remains durable over
time.
Marrow-stimulating techniques, osteochondral allo-
grafts or autografts, autologous chondrocyte implantation,
scaffolds, and focal knee resurfacing implants are some of
the main approaches proposed for the treatment of chondral
and osteochondral lesions of the knee and the ankle. This
article will discuss treatment options focusing on problems
in the surgical management of the entire osteochondral unit
and analyzing their effects on the subchondral bone
structure.
Subchondral bone changes after marrow-stimulating
techniques
Various techniques have been developed to repair full-
thickness cartilage defects, chiefly among them marrow-
stimulation techniques (MST), such as subchondral drilling
[64], abrasion arthroplasty [35], and microfracture [72].
MST attempt to stimulate filling of a cartilage defect with
reparative tissue resulting from perforation of the sub-
chondral bone. Blood and mesenchymal cells from the
underlying marrow cavity form a clot in the defect that
gradually differentiates into a fibrocartilaginous repair tis-
sue [72]. MST procedures, in particular the more recently
introduced microfracture technique, are generally consid-
ered as first-line treatment for full-thickness cartilage
lesions and have demonstrated good to excellent results in
60–80% of patients [55, 71]. There are, however, concerns
over the durability of the repair tissue and hence the clin-
ical outcome, especially in defects that are larger than 2–
4 cm2 and located in areas other than the femoral condyles
[28, 39, 42].
MST have been called ‘‘non-bridge-burning’’ proce-
dures due to the belief that they would not negatively
influence subsequent cartilage repair procedures such as
ACI. Recent studies have demonstrated subchondral
changes in up to one-third of patients treated with micro-
fracture, such as thickening of the subchondral bone, and
formation of subchondral cysts and intralesional osteo-
phytes [42, 55]. The findings are similar to those seen in
chronic defects, which have yielded lower success rates
after any type of cartilage repair, including ACI [26]. This
has prompted concerns that treatment with MST could
negatively impact later cartilage repair procedures.
As the understanding of the underlying pathophysiology
grows, cartilage defects and osteoarthritis have become a
disease of the entire osteochondral unit, rather than a dis-
order limited to surface cartilage alone [9]. One theory
suggests activation of secondary centers of ossification in
the subchondral plate as the initiating event in osteoarthritis
[13]. While the entire osteochondral unit remains the same
thickness, the tidemark advances with corresponding
thinning of the overlying cartilage. This thinner layer of
viscoelastic cartilage overlies a thickened and stiffened
subchondral plate and is therefore more susceptible to
damage from shear forces [4]. A similar mechanism can be
postulated to occur after marrow-stimulation procedures:
several studies have demonstrated a 27–33% incidence
of thickening of the subchondral plate and intralesional
osteophytes [42, 55] (Figs. 1, 2). While there is conflicting
evidence on the effects of previous marrow-stimulation on
subsequent cartilage repair procedures [52, 53], these
changes are regarded as a potential explanation for the
deterioration and failure of microfracture [21, 65, 70]. It
can be theorized that the altered subchondral plate is
responsible for the worse outcomes both in chronic defects
as well as in cartilage defects previously treated with
marrow-stimulation techniques, where one study showed a
failure rate of ACI in previously marrow-stimulated defects
three times higher than in not previously treated defects
[53].
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Bone allografts for subchondral lesions
Osteochondral allograft transplantation has been used in
Orthopedic Surgery for over 20 years to reconstruct severe
osteochondral defects resulting from trauma, malignancy,
and developmental disorders. In current practice in the
United States, osteochondral allografts have also become a
common option for the treatment of comparatively milder
cartilage abnormalities, primarily those also affecting the
subchondral bone, such as osteochondritis dissecans
(OCD). More recently, the indications for allograft have
been broadened to include the revision of failed prior
cartilage repair procedures, especially in the setting of
altered subchondral bone, such as is seen in 30–50% of
patients after marrow stimulation (microfracture, drilling,
and abrasion arthroplasty) [55].
Osteochondral allografting allows replacement of the
entire osteochondral unit (articular cartilage and subchon-
dral bone), thus avoiding the potential negative effects of
altered subchondral bone on cell-based therapy procedures
such as autologous chondrocyte implantation (ACI).
Increasingly, allografts are now also being used as the
primary treatment in situations where other restorative
procedures have demonstrated limited success, such as in
the very large or uncontained defect, or in the older patient
population. Initially, limited by the low number of suitable
grafts, fresh allograft tissue is becoming increasingly
available in the US due to improved harvesting and storage
protocols; however, the supply is still outpaced by a rapidly
increasing demand.
The typical candidate for osteochondral allografting
presents with a large full-thickness chondral or osteo-
chondral defect and has failed prior procedures, such as the
repair of an unstable OCD lesion, microfracture, osteo-
chondral autograft transfer, or ACI. Some lesions preclude
the use of other cartilage repair procedures, either due to
their large size, specific location, or associated deep osse-
ous defects. Localized unipolar lesions larger than 3–
4 cm2, preferably in the femoral condyles, provide for an
optimal environment for osteochondral grafting. Trochlear
lesions can be treated as well but are technically more
challenging due to the more complex geometry of the
articular surface; and for patellar lesions, this technique
represents a salvage option that should be considered once
all else has failed.
Co-morbidities that must be addressed either prior to or
at the time of the osteochondral allografting procedure
include malalignment, ligament deficiency, and meniscal
insufficiency. Bipolar lesions present a relative contrain-
dication and result in less predictable outcomes.
Two techniques are generally utilized for osteochondral
allograft transplantation: the shell and the dowel tech-
niques. For the shell technique, the surgeon removes a
geometric area of cartilage and bone with a bur and fash-
ions a matching graft by hand, which is then secured in
the defect with screw fixation. Technically difficult, and
therefore only rarely used, this technique is advantageous
for unusually shaped defects, such as very oblong lesions,
or defects situated very posteriorly in the femoral condyles,
where a dowel technique is not possible. The dowel tech-
nique, used for the vast majority of patients, is an extension
of the osteochondral autograft technique, but utilizing lar-
ger grafts of 15–30 mm diameter. The cartilage defect
(Fig. 3a) is prepared with a cylindrical reamer (Fig. 3b).
A size-matched hemicondyle is ordered (Fig. 3c), and a
dowel-shaped graft fashioned with the help of an allograft
Fig. 1 CT arthrogram: sagittal view of a previously microfractured
defect with a large intralesional osteophyte with very thin surface
layer of fibrocartilaginous repair tissue
Fig. 2 Intra-operative image depicting the intralesional osteophyte
shown in Fig. 1 after debridement of soft tissue coverage
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workstation (Fig. 3d). The graft is then secured in the
recipient defect by press-fit fixation (Fig. 3e). Mid-term
follow-up studies have demonstrated survival of more than
80% of grafts at 3–10 years [24, 25].
Specific complications include the risk of disease
transmission such as HIV or hepatitis, which is estimated at
less than 1:150,000, as well as graft failure, usually at the
subchondral level with delamination of the articular
cartilage.
Bone autografts for subchondral lesions
Bone autografts are commonly used in general and sports
orthopedics to encourage healing, for example after open-
ing wedge osteotomies; and to address issues of bony
deficiency, for example to address tunnel widening after
failed ACL reconstruction. More recently, the use of bone
autografts in the field of cartilage repair has increased to
address similar issues, as will be discussed by using oste-
ochondritis dissecans (OCD) lesions as an example.
However, the same principles apply when treating any deep
osteochondral defect, irrespective of its etiology and can
also be considered when faced with substantially altered
subchondral bone during the treatment of a cartilage lesion.
The preferred treatment for OCD lesions and osteo-
chondral fractures is primary repair through osteosynthesis.
Chronic OCD lesions are frequently sclerotic, raising
concerns over non-union with screw fixation alone. It has
become accepted treatment to debride the bed of the lesion
of all fibrous tissue and sclerotic bone to encourage heal-
ing. This can be enhanced further by adding bone autograft
to the bed of the defect, which also assists in proper
reduction in the fragment, which can otherwise be recessed
too far into the defect, especially after thorough debride-
ment of sclerotic margins. If the OCD lesion or osteo-
chondral fracture cannot be repaired due to excessive
fragmentation, reconstruction of the defect (Fig. 4a, b) can
be performed with bone grafting and concomitant or staged
cartilage repair.
Traditionally, iliac crest bone graft (ICBG) has been
utilized as an excellent source for bone autograft; however,
this harvest site is associated with substantial post-opera-
tive pain and morbidity. Therefore, alternative sources of
bone graft have been investigated, such as allograft bone.
While a viable source of structural graft, allograft bone
does not provide living cells and is associated with
increased cost. In our practice, the use of autograft bone
from the proximal tibia or distal femur [57] has resulted in
excellent outcomes with no additional cost, reduced mor-
bidity by avoiding ICBG, and increased accessibility for
knee operations, frequently through the same skin incision.
Most commonly, a cortical window is created over the
medial surface of the proximal tibia or at Gerdy’s tubercle
Fig. 3 a–e The dowel
technique for the transplantation
of an osteochondral autograft
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on the lateral aspect, depending on the location of the
incision for the primary procedure. When harvesting bone
graft for a high tibial osteotomy, a small incision can be
made over the medial or lateral femoral epicondyle, pro-
tecting the insertions of the collateral ligaments, to obtain
graft from the distal femur instead. A small window of
approximately 1 9 1 cm is created with an osteotome and
removed. Any cancellous bone attached to the cortex can
be harvested for graft material. A curette can now be used
to harvest as much graft as needed to fill the defect.
Alternatively, it has been helpful to utilize a 10-mm har-
vesting tube from any of the available osteochondral
autograft transfer systems (Fig. 5). By aiming in different
directions, at least 3–4 cores of cancellous bone measuring
10 9 25 mm can be obtained, greatly improving ease and
length of graft harvest. The harvest site can then be filled
with allograft chips or putty and the cortical window is
replaced.
The graft material is now placed into the defect and
compacted with a bone tamp (Fig. 6). The graft is then held
in place with digital pressure and release the tourniquet,
waiting for the resulting clot to solidify and stabilize the
graft. For smaller defects, no additional fixation is required.
In larger defects, a layer of fibrin glue is commonly added,
with or without collagen membrane coverage, to secure the
graft from displacement (Fig. 7). In cases of concurrent
bone grafting and cartilage repair with cell-based therapy
such as autologous chondrocyte implantation (ACI), a
sandwich technique is used, applying the ACI on top of the
membrane-covered bone graft. Lastly, for arthroscopic
bone grafting techniques, the graft is morcellized and
mixed with fibrin glue. Loaded into a syringe with the front
end cut-off, the graft can be delivered into the defect and
impacted with minimal spillage. Note, however, that this
should be performed with the knee dry.
Autologous chondrocyte implantation with scaffolds
and the subchondral bone
In the last 20 years, regenerative techniques, such as first
and second generation autologous chondrocyte implanta-
tion, have emerged as a promising therapeutic option and
several trials [11, 40] have confirmed the good clinical
results of these treatments. Since being introduced in 1987,
the cell-based approach has gained increasing acceptance
and recent studies highlight the long-term durable nature of
this form of treatment due to the production of hyaline-like
cartilage that is mechanically and functionally stable and
integrates into the adjacent articular surface.
Fig. 4 Large OCD lesion
presenting after prior fragment
removal: a arthroscopic and
b open view
Fig. 5 Autogenous bone graft being harvested from the distal femur
with a harvesting tube (different patient—here for grafting of an
opening wedge high tibial osteotomy)
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The recently developed second generation ACI tech-
niques provide similar or superior results than the tradi-
tional ACI technique and simplify the procedure with
marked advantages from a biological and surgical point of
view [41]. This matrix-assisted chondrocyte implantation
approach uses tissue-engineering technology to create a
cartilage-like tissue in a three-dimensional culture system.
Essentially, the concept is based on the use of biodegrad-
able polymers as temporary scaffolds for the in vitro
growth of living cells and their subsequent transplantation
into the defect site.
The interpretation of subchondral bone changes present
after autologous chondrocyte implantation as well as their
correlation with the clinical outcomes is controversial. In
general, bone marrow edema is associated with several
diseases and is often observed in patients complaining of
knee pain. Moreover, in patients with knee osteoarthritis,
bone marrow edema lesions markedly increase the risk for
structural progression of the condition, especially in the
compartment affected by the bone marrow lesions [74].
Considering regenerative procedures, short-term results
reported by some authors [20, 50] showed that the status of
the subchondral bone was significantly correlated with
clinical outcomes. Edema-like signal has been widely
described early after ACI and has been attributed to graft-
immaturity in the immediate post-operative period. Nev-
ertheless, its interpretation remains controversial, and some
authors see the persistence of edema-like signals for more
than 1 year as a predictor for poor clinical outcome, while
other studies regard edema as a sign of undetermined
importance [27, 66].
In a recent MRI analysis of 40 patients treated for car-
tilage lesions with hyaluronan-based arthroscopic autolo-
gous chondrocyte implantation at minimum 5-year follow-
up, the MRI evaluation showed subchondral bone changes
(edema, granulation tissue, cysts, and sclerosis) in 50% of
the patients (data submitted for publication). Even though
the total MOCART score was significantly correlated to the
IKDC subjective evaluation, further analysis did not
demonstrate a significant correlation of specific parameters,
such subchondral edema, with clinical scores. However,
the interpretation of such a high rate of subchondral bone
changes after over 5 years was concerning, and the lack of
correlation to the clinical outcome may have been due to
the low number of patients analyzed. Therefore, all MRIs
performed at different follow-up times and their respective
clinical outcomes were analyzed together. The evaluation
involved 78 knee MRIs, performed at least 24 months after
second generation autologous chondrocyte implantation.
The larger number of MRIs analyzed allowed increased
power to detect any potential correlation between sub-
chondral changes and clinical outcome, and indeed, the
worst results were found in patients affected by bone
marrow edema.
These findings demonstrate the importance of the sub-
chondral bone and the need for further studies to better
clarify its role in the pathologic processes, the importance
Fig. 6 The bone graft has been impacted into the defect
Fig. 7 The bone graft has been covered with fibrin glue and a
collagen membrane for additional support
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of carefully considering this structure in the treatment of
articular surface damage, in the evaluation of the results
over time, and in the determination of the patients
prognosis.
In particular, certain defects, such as those resulting
from osteochondritis dissecans (OCD), osteonecrosis and
more severe trauma are primarily osteochondral in nature
with involvement of subchondral bone. In these patients,
bone grafting and specific surgical procedures for articular
surface reconstruction have been developed [63]. In fact,
surgical treatment should always aim to re-establish the
joint surface in the most anatomical way possible. How-
ever, most of the bioengineered tissues used in clinical
practice were designed to promote healing of the cartilage
layer only, but do not regenerate bone. Importantly, it must
be considered that the subchondral bone may be involved
not only in true osteochondral defects: even focal chondral
defects, if left untreated, may increase in size over time and
present concomitant changes of the underlying subchondral
bone plate, either overgrowth or bone loss.
Articular cartilage and its supporting bone functional
conditions are tightly coupled since injuries of either
adversely affect the entire joint environment. The biome-
chanical perturbations caused by osteochondral alterations
substantially alter pattern and magnitude of contact pres-
sures and cartilage strains in the joint [69]. As such, they
have the potential to contribute to the initiation and
development of osteoarthritis. For this reason, several
authors have highlighted the need for biphasic scaffolds, in
order to reproduce the different biological and functional
requirements for guiding the growth of the two tissues
(bone and cartilage), to result in a predictable and durable
repair. New scaffolds with osteochondral regenerative
potential have been developed and evaluated with promis-
ing preliminary results. Niederauer et al. [59] investigated a
multiphasic implant prototype using poly(D,L)lactide-co-
glycolide as the base material for the treatment of osteo-
chondral defects in goats. Qualitative evaluations showed a
high percentage of hyaline cartilage and good bony resto-
ration, as well as tissue integration with the native cartilage.
Moreover, no difference in healing was found between
seeded and empty scaffolds. Jiang et al. [34] developed a
biphasic cylindrical porous plug of poly(D,L)lactide-co-
glycolide, with the lower portion impregnated with B-tri-
calciumphosphate as the osseous phase. This composite
construct was tested both cell-free and seeded with autol-
ogous chondrocytes, in the femoral condyles of mini-pigs,
and good scaffold integration with cancellous bone for-
mation in the implant periphery was found. In the chondral
phase, hyaline cartilage regeneration was found in cell-
seeded group, whereas only fibrous tissue formed in the
control group. Nagura et al. [58] developed a PLG bio-
absorbable porous scaffold and tested it on full-thickness
osteochondral defects in rabbit. Scaffold absorption with
regeneration of the osteochondral defect was noted. They
supposed that pore size may play an important role for both
restoration and remodeling of cartilage and bone and deg-
radation of PLG scaffold. Schlichting et al. [68] reported
osteochondral defect healing using a polylactide-co-glyco-
lide copolymer with calcium sulfate scaffold in two groups
of sheep. One group was treated with a stiff scaffold, the
other with a modified softer scaffold. Better healing of
osteochondral defects was observed with the stiff scaffold.
Schagemann et al. [67] carried out a study on osteochondral
repair with implantation of cell-loaded and cell-free algi-
nate–gelatin biopolymer hydrogel in sheep. Defects after
treatment with hydrogel plus autologous chondrocytes were
restored with smooth, hyaline-like neo-cartilage and tra-
becular subchondral bone, whereas the cell-free gel treat-
ment revealed slightly inferior regenerate morphology.
However, despite all the pre-clinical studies reported, only
one scaffold used for osteochondral regeneration is cur-
rently available for clinical application. This is a bilayer
porous PLGA-calcium-sulfate biopolymer (TruFit, Smith &
Nephew). Although pre-clinical results appear promising,
there are no controlled studies, and only case reports have
shown favorable results after implantation of these osteo-
chondral substitutes. MRI evaluation at 12 months dem-
onstrated heterogeneous repair tissue and information on
long-term durability is not available [54, 80]. More
recently, Kon et al. utilized an osteochondral nanostruc-
tured biomimetic scaffold with a porous 3D tri-layer com-
posite structure in order to recreate the entire osteochondral
anatomy. The cartilaginous layer, consisting of Type I
collagen, has a smooth surface to favor joint motion. The
intermediate layer (tide-mark-like) consists of a combina-
tion of Type I collagen (60%) and HA (40%), whereas the
lower layer consists of a mineralized blend of Type I col-
lagen (30%) and HA (70%) reproducing the sub-chondral
bone layer. In vitro and animal studies showed good results
in terms of both cartilage and bone tissue formation.
Moreover, similar macroscopic, histological and radio-
graphic results were observed when implanting scaffolds
loaded with autologous chondrocytes or empty scaffolds,
suggesting in situ regeneration through stem cells derived
from the surrounding bone marrow [40]. Thus, this new
osteochondral scaffold has been introduced into clinical
practice as a cell-free approach with promising preliminary
results.
Subchondral bone defects after focal knee resurfacing
implants
The implantation of focal knee resurfacing implants
(Fig. 8) is currently being advocated for the treatment of
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full-thickness chondral and osteochondral defects as an
alternative for marrow-stimulation techniques or osteo-
chondral transplants. These implants consist of an articular
component with a polished surface and a fixation compo-
nent that connects the articular component with the
epiphyseal bone. Suggested indications include defects
caused by trauma, osteonecrosis, localized osteoarthritis
and osteochondritis dissecans in patients older than
40 years [38]. These implants are characterized by good
osseointegration [16, 38]. However, although such
implants are already used in the treatment of localized
cartilage defects in the knee, hip, shoulder and toe, little is
known about their long-term properties and emerging
experimental data serves to caution and to establish a clear
indication for their use.
For example, Custers et al. [15] implanted metal
implants with a 3.5-mm diameter articulating surface in
osteochondral defects in the medial femoral condyle in a
rabbit model. After 4 weeks, cartilage degeneration was
found in the opposing cartilaginous surfaces in the knees
treated with metal implants. This cartilage degeneration
caused by metal implants was significantly higher com-
pared to microfractured or untreated defects. Tibial carti-
lage quality was least compromised when implants were
placed flush compared to deep or protruding position [16].
When defect-size femoral implants were used for the
treatment of osteochondral defects in the medial femoral
condyle in a goat model, this treatment did not prevent
cartilage degeneration in the articulating cartilage of the
medial tibial plateau post-operatively compared with
untreated, empty defects [17] or with defects treated by
microfracture [17]. These experimental data suggest that
caution is warranted using focal knee resurfacing implants
as a treatment for established localized cartilage defects.
In the clinical setting, focal knee resurfacing implants
have been advocated particularly for elderly patients as a
less-invasive means of resurfacing focal articular cartilage
defects. However, implantation in younger patients with
good subchondral bone begets the question of how to treat
the subsequent subchondral bone damage following a
potential removal in the future (Fig. 9). Indications for
implants removal include, for example, persistent pain,
loosening or infection [31]. With sizes of the articular
component often larger than 3 cm2, a deep osteochondral
defect results that has to be treated, either by multiple
osteochondral autografts or by autologous chondrocytes
transplantation, the latter requiring concurrent or staged
restoration of the subchondral bone with bone grafts.
Although focal knee resurfacing implants may be
appropriate for elderly patients as a less-invasive option for
resurfacing localized and deep osteochondral defects, it is
important to avoid unnecessary destruction of the sub-
chondral bone resulting from their implantation, particu-
larly in young patients. Because of the potential problems
that occur after removal of such implants, these implants
should not be recommended for patients who are too young
to undergo unicondylar or total knee arthroplasty as a
revision option. In these patients, restoration of the dam-
aged subchondral bone is preferred using a biological
method. In conclusion, small focal knee resurfacing
implants should not be used in young patients due to the
potential difficulties in restoring the subchondral bone in
case of implant removal.
Fig. 8 HemiCap focal knee resurfacing implant after removal,
showing the polished articular component and the porous-coated
fixation component
Fig. 9 Subchondral bone defect with comparatively normal-appear-
ing subchondral bone after removal of a HemiCap focal knee
resurfacing implant. Note the depth of the subchondral bone defect
caused by the fixation component
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Strategies after failed subchondral bone repair
It is well-known that cartilage defects are difficult to repair.
It is also known that changes in subchondral bone may alter
the biomechanical properties of the subchondral plate and
thus influence the long-term survival of the repair tissue
after different cartilage repair methods. Healthy subchon-
dral bone of lower elasticity is normally present to absorb
much of the forces generated during impulse loading,
protecting the cartilage layer [19]. Similarly after cartilage
repair, the regenerative tissue needs support from healthy
subchondral bone, otherwise the overlying cartilage repair
will ultimately fail. This supporting bone should be strong
and elastic yet deformable [19].
A large number of factors may limit proper bone heal-
ing. The early repair stage may be adversely altered by the
administration of anti-inflammatory medications, immu-
nosuppression, and steroids [3, 8, 22]. Vascularization of
the bone tissue in the first few weeks could also be nega-
tively influenced by nicotine [18, 77, 85]. The patient
should stop smoking at least 3 weeks prior to surgery and,
not resume until after the bone has healed. Radiation [82]
and systemic diseases such as diabetes, rheumatoid
arthritis, and osteoporosis are recognized inhibitors of
successful bone healing and fusion [2, 14, 23]. The surgeon
has to discuss such negative factors before a second
surgery.
Furthermore, the proper amount of stress placed on a
graft varies based on anatomical region and overall sta-
bility of the bone. Resorption may occur in areas where
bone is not exposed to the right type of mechanical stresses
[37]. Subsequently, one has to consider the weight-bearing
characteristics of the patient; for example, whether there is
too much varus or valgus malalignment. Should a con-
comitant unloading osteotomy be performed or is it enough
to use an unloader brace just during the healing period?
The choice of how to treat a failed subchondral repair
depends on the previous method used and the size of the
defect. Small to medium defects can be treated by
implantation of autologous osteochondral plugs (Fig. 10)
to address both the osseous and cartilaginous loss of tissue
[29]. If the defect is deep, multiple purely osseous grafts
from the surrounding bone can be harvested and implanted
first, followed by implantation of osteochondral grafts on
top (Fig. 11). Moderate to larger sized defects can be
treated by autologous chondrocyte implantation using the
sandwich technique (Fig. 12) [10, 36]. The bony defect is
filled with bone graft and periosteum or a collagen mem-
brane is put on top of the bone graft level with the sub-
chondral bone plate. An additional periosteal or collagen
membrane is sutured on top of the cartilage defect, and the
cells are implanted between the two membrane layers. The
bone graft used can be either autologous bone, synthetic
bone, or a combination of both. It is important to tightly
pack the bone graft by careful compression after marrow
stimulation of the defect base to improve vascularization.
The procedure can be performed arthroscopically with
bone graft implanted via a tubular instrument (such as a
syringe), followed by cartilage repair using a seeded
membrane used in combination with fibrin glue; bone paste
and chondral graft [10]. Very large osteochondral defects
are treated by osteochondral allografts [43]. An autologous
alternative is the transfer of the posterior aspect of the
femoral condyle, the mega osteochondral transplantation
(OATS) technology [12]. Finally, if the subchondral bone
has failed but the overlying cartilage is still intact, such as
in avascular necrosis or non-displaced OCD lesions, ret-
rograde drilling and retrograde bone filling is an option. An
ACL drill guide may then be used retrograde for the knee
or a mini vector guide for the ankle to reach the insufficient
bone area leaving the overlying cartilage intact.
Fig. 10 Small to medium sized defects can be treated by standard
implantation of autologous osteochondral plugs
Fig. 11 If the defect is deep, multiple purely osseous grafts can be
harvested from surrounding bone and implanted first into the base of
the defect, followed by more superficial placement of the osteochon-
dral grafts
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Growth factors and other drugs are also an option;
several are available commercially and may be of interest
when treating failed subchondral repair [79]. Biphospho-
nates have been reported to induce osteonecrosis in the
mandible [44]. However, a bone graft can be treated with
BMP-7 to increase new bone production and at the same
time be protected against premature catabolism by a single
dose of a bisphosphonate [30]. Local treatment of a bone-
grafted area with bisphosphonate may diminish the risk of
collapse during revascularization and bone remodeling in a
mechanically loaded bone-grafted areas.
The role of subchondral bone in the pathogenesis of
cartilage damage has likely been underestimated. Sub-
chondral bone is not only an important shock absorber, but
it may also be important for cartilage metabolism. When
there are signs of insufficient subchondral repair, the sur-
geons has to consider revising not only the cartilage defect,
but also address the subchondral bone changes. Careful
pre-operative investigation and planning increases the
chance for a successful outcome.
Treatment strategies for osteochondral defects
of the ankle
Treatment strategies for osteochondral defects of the ankle
have substantially increased over the last decade. Treat-
ment of symptomatic chondral lesions include non-opera-
tive treatment with rest or casting, excision of the lesion,
excision and debridement, excision combined with
debridement and bone marrow stimulation (microfractur-
ing), placement of cancellous bone graft, antegrade
drilling, retrograde drilling, fixation of fragments, osteo-
chondral autograft transplantation, autologous chondrocyte
implantation (ACI), or limited prosthetic replacement.
Goal of these treatments is to resolve symptoms and,
ideally, to prevent the development of osteoarthritis in the
long term. However, there are no long-term follow-up
studies of untreated osteochondral defects that demonstrate
progressive deterioration of the ankle joint. Reports of
patients undergoing ankle replacement or ankle arthrodesis
following OCD are rare. We therefore conclude that in the
ankle joint, the natural history of a talar OCD lesion is
mostly benign.
The reason for treatment is pain. Several factors might
play a role. These include pain caused by rise in intra-
articular pressure, rise in intraosseous pressure, synovial
pain, or bone pain. Patients with localized OCD of the
talus typically do not have joint effusion, and therefore it
is unlikely that increased intra-articular pressure contrib-
utes to the pain. Patients with a talar OCD present with
‘‘deep ankle pain’’. The synovium of the anterior ankle
joint is located directly under the skin and can easily be
palpated. Patient with an OCD of the talus typically do not
have recognizable tenderness on palpation of the syno-
vium. Some patients have secondary synovial pain, which
they can differentiate from the disabling deep ankle pain
caused by the OCD. This deep ankle pain occurs during
weight bearing and cannot be reproduced during physical
examination. The nerve endings in the subchondral bone
are the most probable cause of this pain [48]. Treatment
strategies therefore have to concentrate on the subchondral
bone rather than on the cartilage. Detection of the bone
lesion is likewise more important than detecting the car-
tilage lesion itself. For detection of a talar osteochondral
defect CT scan and MRI have shown similar accuracy
[76]. A CT scan is the diagnostic strategy of choice. For
pre-operative planning, CT scan is preferred since it
demonstrates the exact size and location of the subchon-
dral lesion. It is the subchondral lesion that has to be
treated in order to treat the pain. The current preferred
strategy for talar OCD is excision curettage and bone
marrow stimulation [83]. Following excision and
debridement of the lesion multiple connections with the
subchondral bone are created by removing the calcified
zone and perforating the subchondral plate. Intra-osseous
blood vessels are disrupted and the release of growth
factors leads to the formation of a fibrin clot. The for-
mation of local new blood vessels is stimulated, bone
marrow cells are introduced in the defect and fibrocarti-
lage tissue is formed. The overall success rate has reported
to be 85%.
Fig. 12 Moderate and deep defects can be treated by autologous
chondrocyte implantation using the sandwich technique. Bone graft is
packed into the base of the defect to reconstitute the bony defect, then
covered by periosteum or a membrane. A periosteal flap or collagen
membrane is then sutured to the surrounding cartilage according to
standard ACI technique, and the cells are implanted between the two
membranes
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Subchondral bone changes associated
with meniscal lesions
Knee menisci are mobile fibrocartilaginous semilunar
shock absorbers and load transmitters. They are fixed to the
tibial plateau and to a lesser extent to the femur. A com-
plete loss of the meniscus leads to an increase in tibio-
femoral contact pressures and a significant decrease in the
tibiofemoral contact areas [6, 61]. Peak contact stresses in
the medial compartment increase proportionally to the
amount of meniscus removed [45, 84], starting with as little
as 20% of removed meniscal tissue [75]. As a consequence,
knees without menisci are at great risk for the development
of cartilage damage and osteoarthritis. Hence, maximum
preservation of tissue should be the ultimate goal of any
meniscal surgery.
Partial or total meniscectomy results in increased pres-
sure on the articular cartilage. Finite element analysis
revealed that both peak values and shear stress in the
articular cartilage changed after meniscectomy, potentially
leading to 2 types of cartilage damage [81]: Type 1 rep-
resents cartilage degeneration without disruption of the
underlying bone or the calcified cartilage layer [5]. Type 2
represents a subchondral fracture with or without injury to
the overlying cartilage [5] and might be a result of the
measured 140% increase in shear stress at the articular
cartilage—bone interface.
The biomechanical consequences of meniscal pathology
on the underlying subchondral bone have been evaluated
using quantitative CT or DXA measurements [47, 60, 62].
A close association between meniscal damage and
increased subchondral bone mineral density in the tibial
plateau of the corresponding tibiofemoral compartment has
been found. In comparison with healthy knees, medial
partial or total meniscectomy resulted in posteromedial
displacement of the area of maximum density by approx-
imately 4 mm. These changes occurred within the first
years after surgery and remained stable between 5- and 10-
year follow-up [60]. Similarly, an analysis of changes in
trabecular bone strain in the proximal tibia as a result of
partial and complete meniscectomy revealed altered load
transfer from the articular surface through the trabecular
region to the diaphysis [51]. As expected, the greatest
change was seen in the subchondral region after complete
meniscectomy. These bone changes indicate a relation
between local bone density and bone marrow lesions [46].
Clinically, this might correlate with the commonly seen
juxta-articular pain in patients in the early stages after
partial or total meniscectomies.
The exact role of meniscal damage in the pathophysi-
ology of osteoarthritis still remains to be determined [47].
It is highly prevalent in osteoarthritis [7], and recently it
has been shown that these meniscal changes are predictive
of structural progression of osteoarthritis [32]. One of the
factors in need of further analysis is the inconsistency
between the patterns of meniscal versus chondral damage
in osteoarthritic patients [73]: it can frequently be observed
that a segment of the meniscus, which was thought to
experience an excessive load, was yet well preserved, or
that cartilage lesions on the tibial plateau were located
underneath an intact meniscus. These findings demonstrate
that the exact interactions between the meniscus-cartilage-
subchondral bone complex still largely remain unknown.
Application of evidence-based medicine
to the subchondral bone
Evidence-based medicine has gained popularity in ortho-
pedic surgery. Historically, surgeons have practiced what
they learned from senior colleagues and then refined these
techniques through their own experience and mistakes. It is
also a fact that the majority of new techniques have been
adopted in clinical practice without evidence from a ran-
domized controlled trial [1]. Randomized controlled trials
having enough power are difficult to perform in surgery.
However, to move forward, randomized controlled trials
are needed with long-term follow-up as an important sup-
plement to registers and observational studies.
Fifty years ago, bone and subchondral bone were main
targets in osteochondral repair. Bone grafting using auto-
and allografts has a long tradition in orthopedic surgery. For
decades, subchondral bone was the main focus in cartilage
repair. Scientists and surgeons believed that cartilage was
impossible to regenerate in adults, and repair was initiated
by debridement and drilling. Undoubtedly, progress has
been made along the way, but in a sense we have closed the
circle and are back to where we started. Many believed that
cell-based therapies had solved the problem of repairing
osteochondral defects. However, randomized controlled
trials, clinical studies and meta-analyses have not given us
the necessary evidence. A Cochrane review did not find
evidence for superiority of any of the studied techniques for
cartilage repair [78]. Another paper by Jakobsen et al. [33]
concluded that the majority of studies on cartilage had a low
methodological quality. Recently, another systematic
review of the treatment of focal articular cartilage defects in
the knee was published [49]. They identified five random-
ized controlled trials and concluded that no technique
consistently had superior results compared with the others.
A weakness of all studies was that no control (non-opera-
tive) groups were used. It is also fact that no technique
available today has been able in clinical studies to prove the
regeneration of normal hyaline cartilage. No doubt that
tissue engineering has a great potential in osteochondral
repair, and most of us realize that previous and current
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marrow-stimulation techniques are not the solutions for the
future. However, new techniques have to be carefully
evaluated before they are generally adopted.
Recently, subchondral bone again has come more into
the spotlight again. Better understanding of the subchon-
dral bone, and the interface and interaction between carti-
lage and the subchondral bone may help us solve some of
these problems. This field of osteoarticular repair continues
to evolve. New scaffolds are being introduced without
thorough clinical evaluation. Companies sponsor testing of
their own products in registries or even randomized con-
trolled trials, injecting potential bias into these studies.
Independent randomized controlled trials, registers and
observational studies are needed to improve in this field.
These principles also have to be applied to the new treat-
ments aimed at repair of the subchondral bone. Random-
ized controlled trials are best suited for answering a
therapeutic question, but they are difficult to perform
and not always feasible. Randomized controlled trials and
observational studies need to include enough patients, and
therefore multi-center studies (national and international)
having adequate power will be the future. Observational
studies and even case series will still be useful by providing
important information on natural history, prognostic fac-
tors, adverse treatment effects, and prevalence of certain
diseases or outcomes [56].
Conclusion
The understanding of joint homeostasis and the interaction
of cartilage and subchondral bone continues to evolve.
After years of focusing almost exclusively on treating the
easily accessible surface lesion, it is becoming apparent
that without a healthy subchondral bed, the entire osteo-
chondral unit is likely to fail. The future of cartilage repair
lies in better diagnostics to properly recognize alterations
in the subchondral bone that might compromise isolated
cartilage repair, as well as advanced treatment options that
will allow us to replace the entire osteochondral unit,
should this become necessary. To this end, tissue-engi-
neering techniques will be needed to generate a ready
supply of osteochondral transplants that address the issues
of limited autograft availability, as well as concerns over
the use of allografts.
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